93 related articles for article (PubMed ID: 127655)
1. A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia.
Sacks KL; Olweny C; Mann DL; Simon R; Johnson GE; Poplack DG; Leventhal BG
Cancer Res; 1975 Dec; 35(12):3715-20. PubMed ID: 127655
[TBL] [Abstract][Full Text] [Related]
2. Human antisera detecting leukemia-associated antigens on autochthonous tumor cells.
Mann DL; Leventhal B; Halterman R
J Natl Cancer Inst; 1975 Feb; 54(2):345-7. PubMed ID: 1113320
[TBL] [Abstract][Full Text] [Related]
3. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
4. Human leukemia antigen. I. Production and characterization of antisera.
Billing R; Terasaki PI
J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
[No Abstract] [Full Text] [Related]
5. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in previously treated acute lymphatic leukemia.
Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
[No Abstract] [Full Text] [Related]
7. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
Miale TD; Yocum D; Yocum C
Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
[TBL] [Abstract][Full Text] [Related]
8. An acute-leukemia antigen: correlation with clinical status.
Halterman RH; Leventhal BG; Mann DL
N Engl J Med; 1972 Dec; 287(25):1272-4. PubMed ID: 4508573
[No Abstract] [Full Text] [Related]
9. Attempts at immunotherapy of 100 patients with acute lymphoid leukemia: some factors influencing results.
Mathé G; Pouillart P; Schwarzenberg L; Amiel JL; Schneider M; Hayat M; De Vassal F; Jasmin C; Rosenfeld C; Weiner R; Rappaport H
Natl Cancer Inst Monogr; 1972 Dec; 35():361-72. PubMed ID: 4512322
[No Abstract] [Full Text] [Related]
10. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
Herberman RB; Nam JM
J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788
[No Abstract] [Full Text] [Related]
11. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H
Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172
[TBL] [Abstract][Full Text] [Related]
12. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in the management of myelogenous leukemia.
Fairley GH
Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553
[TBL] [Abstract][Full Text] [Related]
14. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
Chapuis BJ; Powles R; Alexander P
Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
[TBL] [Abstract][Full Text] [Related]
15. Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation.
Pfeiffer M; Stanojevic S; Feuchtinger T; Greil J; Handgretinger R; Barbin K; Jung G; Martin D; Niethammer D; Lang P
Bone Marrow Transplant; 2005 Jul; 36(2):91-7. PubMed ID: 15908973
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
Suzuki M
Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
[TBL] [Abstract][Full Text] [Related]
17. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
18. Immune reactivity of leukemia patients to autologous blast cells.
Leventhal BG; Halterman RH; Rosenberg EB; Herberman RB
Cancer Res; 1972 Sep; 32(9):1820-5. PubMed ID: 4264526
[No Abstract] [Full Text] [Related]
19. Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins.
Goldmacher VS; Anderson J; Blättler WA; Lambert JM; Senter PD
J Immunol; 1985 Dec; 135(6):3648-51. PubMed ID: 2933450
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
Bach ML; Bach FH; Zoschke DC
Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
